Biomarker for diagnosis and prognosis of Multiple Sclerosis (MS)

Patent number:

EP24382907

No items found.

Countries:

Spain

Regions:

Community of Madrid

Centers:

CSIC, UNIVERSIDAD AUTONOMA DE MADRID, CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Novel biomarker for diagnosis and prognosis - Minimally invasive method through blood or CFS extraction - Known molecular mechanism of action - Novel pre-clinical model for MS

Comments

Other related patents

Health

PLATELET FUNCTIONALITY FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE

Countries

Spain

Health

ANDROGRAPHOLIDE DERIVATIVE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES ASSOCIATED WITH A CYTOKINE STORM

Countries

Spain

Health

TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER

Countries

Spain

Get back to patents directory